Combined Oral Contraceptives As Victims of Drug Interactions
Drug Metabolism and Disposition · 2023-06 · 51 (6) · 718-732
DOI: 10.1124/dmd.122.000854 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2023-06. Verfasst von Li Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver S…. Hauptthemen laut MEDLINE: Contraceptives, Oral, Combined, Progestins. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
- Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland yanhui.lu@fda.hhs.gov.
Zitieren
APA
Li, L., Yang, X., Tran, D., Seo, S. K., & Lu, Y. (2023). Combined Oral Contraceptives As Victims of Drug Interactions. Drug Metabolism and Disposition, 51(6), 718-732. https://doi.org/10.1124/dmd.122.000854
Vancouver
Li L, Yang X, Tran D, Seo SK, Lu Y. Combined Oral Contraceptives As Victims of Drug Interactions. Drug Metabolism and Disposition. 2023;51(6):718-732. doi:10.1124/dmd.122.000854
BibTeX
@article{Li2023,
author = {Li, Li and Yang, Xinning and Tran, Doanh and Seo, Shirley K and Lu, Yanhui},
title = {Combined Oral Contraceptives As Victims of Drug Interactions},
journal = {Drug Metabolism and Disposition},
year = {2023},
volume = {51},
number = {6},
pages = {718--732},
doi = {10.1124/dmd.122.000854}
}
EUVIMED